AlumiFuel Power Corporation, formerly Inhibiton Therapeutics, Inc., is a development-stage company. The Company is focused on the research and development of new cancer therapeutic agents and cancer fighting drugs called targeted therapies. These new drugs identify molecular causes of cancer and inhibit the signals that cancer cells need to multiply. In May 2009, the Company completed the acquisition of HPI Partners, LLC (HPIP) and its operating subsidiary, AlumiFuel Power, Inc. (API) of Philadelphia, Pennsylvania. API is an alternative energy company that generates hydrogen gas and steam for multiple niche applications requiring onsite, on-demand fuel sources. API’s hydrogen drives fuel cells for back-up, remote, and portable power, fills inflatable devices, such as weather balloons.